ライフサイエンスコーパス: cava

1 ral vein through the adjoining inferior vena cava.

2 4) and C57BL/6 mice (n = 5), using the vena cava.

3 otein in TD compared with the aorta and vena cava.

4 al four chamber, and subcostal inferior vena cava.

5 of the right lung entering the superior vena cava.

6 arterioles, or ligation of the inferior vena cava.

7 left atrial appendage and the superior vena cava.

8 the right ventricular apex and superior vena cava.

9 r between the right atrium and superior vena cava.

10 ial ligation (stenosis) of the inferior vena cava.

11 g filter migration or thrombosis of the vena cava.

12 sequence, and persistent left superior vena cava.

13 ased thrombus frequency in the inferior vena cava.

14 ated and severed at the junction to the vena cava.

15 nalis, RA free wall, and right superior vena cava.

16 ide the coronary sinus via the superior vena cava.

17 , RV size, and dilation of the inferior vena cava.

18 However, it does require clamping of the cava.

19 was less than 60 mm Hg after clamping of the cava.

20 usion of [14C]lactate into the inferior vena cava.

21 for cannulation of the swine aorta and vena cava.

22 ery=26, pulmonary vein=21, and superior vena cava=12).

23 ent, including persistent left superior vena cava (13%) and partial anomalous pulmonary venous return

24 cending aorta, 191 (121, 261); superior vena cava, 137 (77, 197); ductus arteriosus, 187 (109, 265);

25 (16/47, 34%), persistent left superior vena cava (14/47, 30%), and abnormal branching of the right p

26 7 +/- 2%), thorax (14 +/- 2%), inferior vena cava (23 +/- 2%) and liver (23 +/- 2%) (all P </= 0.005

27 ascending aorta, 41 (29, 53); superior vena cava, 29 (15, 43); ductus arteriosus, 41 (25, 57); desce

28 descending thoracic aorta and inferior vena cava, a flow probe around the proximal left circumflex c

29 s achieved by cannulating the aorta and vena cava after death.

30 phrenic nerve pacing from the superior vena cava, all patients underwent diaphragmatic electromyogra

31 planted by end-to-side aorta-aorta and porto-cava anastomoses and end-to-end colorectal anastomosis.

32 that most commonly affect the inferior vena cava and account for 5% of all leiomyosarcomas.

33 For the superior vena cava and brachiocephalic veins, the reconstructions at 1

34 limited the evaluation of the inferior vena cava and common iliac veins near the confluence.

35 o the left subclavian vein and superior vena cava and evaluated for up to 90 minutes.

36 e adrenal vein drainage to the inferior vena cava and hepatic vein or of the inferior phrenic vein (n

37 or treatment by evaluating the inferior vena cava and other cardiac structures.Lung ultrasound can no

38 l vein, and hepatic vein) and infusion (vena cava and portal vein) catheters and flow probes (hepatic

39 est, large-vessel anastomosis (superior vena cava and pulmonary artery [PA] or bidirectional Glenn op

40 (>3 mm) apposition between the inferior vena cava and pulmonary venous atrium (cavoatrial overlap).

41 region of overlap between the inferior vena cava and pulmonary venous atrium is feasible.

42 T1 of blood in the infrarenal inferior vena cava and renal veins after intravenous administration of

43 ular balloon positioned at the superior vena cava and right atrial junction (SVC-RAJ) reduces sodium

44 r bolus dispersion in blood between the vena cava and the arterial tree was applied.

45 transformation that linked the superior vena cava and the coronary sinus from the CT model with a cat

46 Similarly, the superior vena cava and the coronary sinus were also reconstructed from

47 Tumors invading the vena cava and/or the hepatocaval confluence are indications f

48 elet deposition in the ligated inferior vena cava, and diminished platelet activation in vitro.

49 t coronary artery (RCA) to the inferior vena cava, and from the RCA to the tricuspid valve annulus we

50 the abdomen, heart, chest, and inferior vena cava, and many variations in technique, protocols, and i

51 eptal defects, persistent left superior vena cava, and patent ductus arteriosus, were present in 32%

52 ing transient occlusion of the inferior vena cava, and repeat measurements were made after 1 (n=10) a

53 n perfusion into the portal or inferior vena cava, and was confirmed by histological evaluations and

54 ced by flow restriction in the inferior vena cava, APP-KO mice, as well as chimeric mice with selecti

55 ed unequivocally in the murine inferior vena cava as hot spots in vivo by simultaneous acquisition of

56 cavity, left atrial cavity, or inferior vena cava as the IDIF.

57 s a 17% difference in the image-derived vena cava blood activity at 60 min, compared with the ex vivo

58 0%), whereas 55% +/- 19 of the inferior vena cava blood flowed to the left PA (range, 22%-82%).

59 circulation, 87% +/- 13 of the superior vena cava blood flowed to the right PA (range, 63%-100%), whe

60 eta isoform expressed equally in TD and vena cava, both being approximately 2 times higher than that

61 ge of peak activity was observed in the vena cava, but the area under the curve over 2 min was simila

62 ion with reconstruction of the inferior vena cava can be performed in selected cases.

63 rate of 1-2 L/min, with drainage of the vena cava, can achieve deep to profound hypothermia of vital

64 Superior vena cava catheterization interventions between August 1984 a

65 measures, pulse generator and superior vena cava coil location, and angle of lead exit from the pock

66 nce interval 0.65-0.89) or the inferior vena cava collapsibility index (area under the curve 0.66; 95

67 essure (R = 0.58), whereas the inferior vena cava collapsibility index and the internal jugular vein

68 s, with a significantly higher inferior vena cava collapsibility index on day 0 than nonacidotic pati

69 ntral venous pressure than the inferior vena cava collapsibility index or the internal jugular vein a

70 Inferior vena cava collapsibility index was not an independent predict

71 stroke volume index, and high inferior vena cava collapsibility index, which improved with subsequen

72 ontractility and assessment of inferior vena cava collapsibility.

73 nt a unique case, in which the inferior vena cava compression by a total artificial heart was initial

74 he average distance to the RHV-inferior vena cava confluence was 28.7 mm.

75 ailable in 65 patients, as the inferior vena cava could not be visualized in two patients.

76 nction of the right atrium and superior vena cava, crista terminalis, tricuspid valve isthmus, corona

77 Transmural pressure of the superior vena cava decreased during inspiration, whereas the transmura

78 ween the right portal vein and inferior vena cava detected on postnatal ultrasound examination.

79 An inferior vena cava diameter < 2 cm predicted a central venous pressure

80 sure (< 10 mm Hg) was 0.91 for inferior vena cava diameter (95% confidence interval 0.84-0.98), which

81 sophageal echocardiography, of inferior vena cava diameter (IVC) measured using transthoracic echocar

82 udy, respiratory variations of superior vena cava diameter (SVC) measured using transesophageal echoc

83 The maximal inferior vena cava diameter correlated moderately with central venous

84 s pressure after adjusting for inferior vena cava diameter in a multiple linear regression model.

85 sopressor support, the maximal inferior vena cava diameter is a more robust estimate of central venou

86 Respiratory variation in vena cava diameter measured by ultrasound (distensibility ind

87 The proximal mouse vena cava diameter was 2.54 +/- 0.30 mm.

88 idth ratio (aspect ratio), the inferior vena cava diameter, and the percent collapse of the inferior

89 of the central isthmus (RCA to inferior vena cava distance).

90 Patients with less vena cava distensibility were not as likely to be fluid respo

91 he collapsibility index of the inferior vena cava during a deep standardized inspiration is a simple,

92 nto the grafts through the suprahepatic vena cava during cold storage (VSOP-NO group; n=20).

93 l expression pattern in mouse aorta vs. vena cava ECs, which cannot be explained by the difference in

94 n they become firmly embedded along the vena cava endothelium.

95 Vena cava filter (VCF) placement for pulmonary embolism (PE)

96 y were assigned to retrievable inferior vena cava filter implantation plus anticoagulation (filter gr

97 Insertion of a retrievable inferior vena cava filter in patients randomized to the filter group.

98 h a significant bleeding risk, inferior vena cava filter insertion compared with anticoagulant therap

99 sessed the association between inferior vena cava filter insertion for known significant bleeding ris

100 cal pulmonary embolectomy, and inferior vena cava filter insertion.

101 Trauma patients and inferior vena cava filter placements were excluded.

102 lism, the use of a retrievable inferior vena cava filter plus anticoagulation compared with anticoagu

103 ombosis risk factors, avoiding inferior vena cava filter usage except in specified circumstances, avo

104 The effectiveness of inferior vena cava filter use among patients with acute symptomatic VT

105 (previous thromboembolism, preoperative vena cava filter, hypoventilation, pulmonary hypertension), a

106 in (29%), dalteparin (40%), or inferior vena cava filters (20%) were not statistically different (p =

107 rombolytic drugs (3 patients), inferior vena cava filters (3 patients) and, eventually, warfarin (11

108 Evidence that vena cava filters (VCFs) are beneficial is limited.

109 e in the society guidelines, the use of vena cava filters (VCFs) continues to rise.

110 Although retrievable inferior vena cava filters are frequently used in addition to anticoag

111 Limited evidence suggests that vena cava filters are only modestly efficacious for preventio

112 tions such as thrombolysis and inferior vena cava filters are reserved for limited circumstances.

113 o define prolonged retrievable inferior vena cava filters dwell time by determining the inflection po

114 However, mechanical approaches such as vena cava filters have high complication and treatment failur

115 ecent trial data do not support insertion of cava filters in patients who can receive anticoagulant t

116 tigate the survival effects of inferior vena cava filters in patients with venous thromboembolism (VT

117 Patients with retrievable inferior vena cava filters in place beyond 7 months may benefit from r

118 Although chronically implanted inferior vena cava filters may result in filter-related morbidity, the

119 rm the management of fractured inferior vena cava filters on the basis of results from a tertiary ref

120 effective in removing embedded inferior vena cava filters refractory to standard retrieval and high f

121 Superior vena cava filters should be avoided.

122 The use of prophylactic vena cava filters should be re-examined.

123 l further data emerge, thrombolysis and vena cava filters should be reserved for patients in whom ant

124 Vena cava filters were placed in 3,883 patients, 86% as PE pr

125 Inferior vena cava filters were placed in 46%.

126 acted retrieval of retrievable inferior vena cava filters with prolonged dwell times; however, there

127 eding tube placement, tracheostomy, and vena cava filters) among nursing home residents to rates amon

128 icacy of thrombolytic therapy, inferior vena cava filters, and embolectomy during pregnancy.

129 best reserved for severe VTE; inferior vena cava filters, ideally the retrievable variety, should be

130 th in placement of retrievable inferior vena cava filters, retrieval rates remain low.

131 iminished by leg compression devices or vena cava filters.

132 enteral feeding tubes, and insertion of vena cava filters.

133 ion may be more effective than inferior vena cava filtration devices for treating venous thromboembol

134 w were performed by increasing inferior vena cava flow.

135 fibrillation triggered from a superior vena cava focus (1 patient) adjacent to the right PN or epica

136 ned resection of the liver and inferior vena cava for hepatic malignancy.

137 ism (five of 23; 22%), and the inferior vena cava (four of 23; 17%).

138 stomosis of liver allograft to a Dacron vena cava graft can be a feasible solution if traditional ana

139 index of collapsibility of the superior vena cava>/=36%), inotropic support (left ventricular fractio

140 Involvement of the inferior vena cava has traditionally been considered a contraindicatio

141 nd the posterior margin of the inferior vena cava (hilar-caval line) on lateral radiographs; this lin

142 sis created by ligation of the inferior vena cava, HO-1 expression is markedly induced.

143 Following ligation of the inferior vena cava, HO-1(-/-) mice exhibited increased nuclear factor

144 r; n = 7) or infusion into the inferior vena cava (Humulin R; n = 6) using an algorithm to match plas

145 Vena cava IDIF (n = 7) was compared with the left ventricular

146 acute insulin treatment, using a mouse vena cava IDIF approach.

147 The mouse vena cava IDIF provides repeatable assessment of the blood ti

148 l glucose uptake rates (rMGU) using the vena cava IDIF were calculated at baseline (n = 8), after ind

149 the following severe injuries: aortic, vena cava, iliac vessels, cardiac, grade IV/V liver injuries,

150 s was systematically assessed using the vena cava image-derived blood input function (IDIF).

151 idney, brain, lung, vitreous humor, and vena cava in comparison to untreated controls (P </= .05).

152 tissues, such as the aorta and inferior vena cava, in which Mypt1 E23 is predominately skipped.

153 mbosis induced by flow reduction in the vena cava inferior, we identified blood-derived high-mobility

154 try and flow rates through the superior vena cava, inferior vena cava, left pulmonary artery, and rig

155 We hypothesize that inferior vena cava-inferior atrial ganglionated plexus nerve activity

156 adable TEVGs were implanted as inferior vena cava interposition conduits in 2 groups of C57BL/6 mice

157 t were surgically implanted as inferior vena cava interposition grafts in SCID/bg mice.

158 e therapeutic modalities (thrombolysis, vena cava interruption, venous stenting).

159 Persistent left superior vena cava is a rare but important congenital vascular anomaly

160 ionally, the transmural pressure of the vena cava is decreased, whereas the transmural pressure of th

161 ygen saturation (ScvO2) in the superior vena cava is predominantly determined by cardiac output, arte

162 thrombectomy even when cross-clamping of the cava is required.

163 Adjunctive ablation included superior vena cava isolation in 6 patients, cavotricuspid isthmus abla

164 atment of chronic occlusion of inferior vena cava (IVC) and iliocaval confluence with angioplasty and

165 incidental finding of complete inferior vena cava (IVC) and obliteration.

166 lonRACK (1.5 nmol) through the inferior vena cava (IVC) and subsequently submerged in psiepsilonRACK

167 e IPVE, and using the aorta or inferior vena cava (IVC) as the input function.

168 ide diameters of the aorta and inferior vena cava (IVC) at the top of L2 and the bottom of L4 and to

169 ailure to remove a retrievable inferior vena cava (IVC) filter can cause severe complications with hi

170 implantation of an absorbable inferior vena cava (IVC) filter in a swine model.

171 ping heparin and warfarin, and inferior vena cava (IVC) filter placement were not independent predict

172 ationship between prophylactic inferior vena cava (IVC) filter use, mortality, and VTE.

173 Inferior vena cava (IVC) filters are widely used for prevention of pul

174 The use of inferior vena cava (IVC) filters for prevention of venous thromboembol

175 The use of inferior vena cava (IVC) filters in this population has been increasin

176 ed on the role of prophylactic inferior vena cava (IVC) filters to prevent PE.

177 anticoagulation, placement of inferior vena cava (IVC) filters, clinical outcomes, and comments rega

178 studies concerning the use of inferior vena cava (IVC) filters.

179 loop reentry (LLR) around the inferior vena cava (IVC) has been described recently.

180 ded control) were implanted as inferior vena cava (IVC) interposition grafts in juvenile lambs.

181 Obstruction of the inferior vena cava (IVC) is infrequent, membranous obstruction of the

182 littermates underwent partial inferior vena cava (IVC) ligation to induce venous thrombosis.

183 8-hour flow restriction in the inferior vena cava (IVC) results in the development of thrombi structu

184 e, using a murine DVT model of inferior vena cava (IVC) stenosis, we demonstrate that mice with gener

185 Inferior vena cava (IVC) thrombosis is generally a contraindication to

186 chronic iliofemoral (I-F) and inferior vena cava (IVC) thrombosis.

187 associated with renal vein or inferior vena cava (IVC) thrombus in up to 10% of cases.

188 PV access from the inferior vena cava (IVC) to the main PV was performed in eight pigs by

189 been suggested for the use of inferior vena cava (IVC) value instead of FHVP to calculate HVPG when

190 of the hepatic segment of the inferior vena cava (IVC) were the vascular anomalies.

191 profile of the mouse aorta and inferior vena cava (IVC), not restricting our analysis to the endothel

192 tion and reconstruction of the inferior vena cava (IVC), were reviewed.

193 Ten inferior vena cava (IVC)-SMV punctures were performed in six pigs.

194 tumors with extension into the inferior vena cava (IVC).

195 infrahepatic and suprahepatic inferior vena cava (IVC).

196 hrough the superior vena cava, inferior vena cava, left pulmonary artery, and right pulmonary artery.

197 Baseline renal vein and inferior vena cava levels of inflammatory markers were measured and th

198 ity to venous thrombosis after inferior vena cava ligation at 12 or 18 months of age (P<0.05 versus 4

199 after carotid artery injury or inferior vena cava ligation.

200 ease the theoretical risk of a positive vena cava margin or hematologic metastases.

201 of the mesentericoportal vein (n = 24), vena cava (n = 3), or hepatic vein (n = 3).

202 Inferior vena cava occlusion at all experimental stages (baseline, dob

203 orary preload reduction during inferior vena cava occlusion initially induced an expansion of LV end-

204 vena cava thrombosis, chronic inferior vena cava occlusion, and pain from retroperitoneal or bowel p

205 oop data obtained during acute inferior vena cava occlusion.

206 Venous thrombosis was induced in the vena cava of BALB/C mice, and temporal changes in T1 relaxati

207 thrombosis was induced in the inferior vena cava of male BALB/C mice.

208 atelet microparticles into the inferior vena cava of mice and harvested endothelial cells from the pu

209 nor blood withdrawal from the superior vena cava or carotid artery elicited USV from pups in their h

210 r reconstruction of either the inferior vena cava or hepatic veins was performed in five patients.

211 Despite significant inferior vena cava or hepatic venous compression in 65%, hepatic funct

212 kg) kg of whom 4 had occluded inferior vena cava or iliac veins and 2 had previous complex vascular

213 of a roughened catheter into either the vena cava or the aorta.

214 ganglia; (3) occlusion of the inferior vena cava or thoracic aorta; (4) transient ventricular ischae

215 index of collapsibility of the superior vena cava), or increased vasopressor support (right ventricul

216 ridge, crista terminalis, and superior vena cava); or arm 3, standard approach + ablation of left at

217 omy to the inferior vena cava, superior vena cava, or tricuspid annulus or by ablating focally in the

218 trategies including continuous superior vena cava oximetry (SvO2), phenoxybenzamine (POB), strategies

219 suscitation and fluid removal, superior vena cava oxygen saturation, goal-directed, coagulation, immu

220 the lower of the superior and inferior vena cava oxygen saturations.

221 .005), whereas persistent left superior vena cava (P=0.85), ventricular septal defect (P=0.12), and b

222 ium in late frames as compared with the vena cava (percentage injected dose per gram, ctl: 21.4+/-6.1

223 Vena cava pertinent diameters were measured 15-20 mm caudal t

224 hrough partial ligation of the inferior vena cava (pIVCL).

225 a rare case of persistent left superior vena cava (PLSVC) with absent right superior vena cava (RSVC)

226 th extensive thromboses of the inferior vena cava, portal vein, and hepatic veins, was successfully m

227 bject, a congenital left-sided superior vena cava precluded right-sided capture.

228 ients had significantly higher inferior vena cava pressures (15.6 versus 13.7 mm Hg; P=0.007), but on

229 ructed or reimplanted into the inferior vena cava primarily (n = 8) or using segments of the portal v

230 partial-volume correction, the inferior vena cava provides a reliable and reproducible IDIF for Patla

231 he collapsibility index of the inferior vena cava recorded during a deep standardized inspiration pre

232 uter modeling was used to determine the vena cava recovery coefficient.

233 ral cortex, tympanic membrane, inferior vena cava, rectal temperatures, electrocardiogram, arterial b

234 Superior vena cava-related symptoms occur in only 50% of patients with

235 fulness of respiratory variation in the vena cava requires confirmatory studies.

236 sed to the abdominal aorta and inferior vena cava, respectively, of the (splenectomized) recipient.

237 recipient abdominal aorta and inferior vena cava, respectively.

238 ifferences in pressure between inferior vena cava, right atrium, and left atrium were found.

239 After catheterization of the inferior vena cava, right atrium, foramen ovale, and left atrium with

240 Aortic or superior vena cava rim deficiencies were more common in cases than in

241 cava (PLSVC) with absent right superior vena cava (RSVC).

242 The presented IDIF from the vena cava showed a robust determination of CMRGlc using eithe

243 the lowest proportion was for inferior vena cava size [75%]).

244 for (aortic valve was 91% and inferior vena cava size was 58%).

245 ic valve was 96% [highest] and inferior vena cava size was 78% [lowest]) and decreased when nonvisual

246 When adjusted for age, LVEF, inferior vena cava size, and RV size and function, survival was worse

247 Hypothetical origin of 5-HMF in Cava sparkling wine is discussed.

248 e structure of a potential ageing marker for Cava sparkling wine.

249 Four different cava sparkling wines were monitored during an accelerate

250 Hepatic vein-cava stenoses occurred after a mean of 37.2 +/- 35.2 mon

251 32 LRD, 3 RSS, and 3 FS, while hepatic vein-cava stenoses occurred in 2 LRD, 8 RSS, and 2 FS.

252 patients (38 portal vein and 12 hepatic vein-cava stenoses).

253 A young woman with a benign superior vena cava stenosis due to a tunneled internal jugular vein di

254 bearing and control mice in an inferior vena cava stenosis model.

255 produced a thrombus 48 h after inferior vena cava stenosis whereas 90% of wild-type mice did.

256 h at the junction of the right superior vena cava, sulcus terminalis, and RA free wall, corresponding

257 m the lateral atriotomy to the inferior vena cava, superior vena cava, or tricuspid annulus or by abl

258 origin, those arising from the superior vena cava (SVC) can precipitate atrial fibrillation (AF).

259 PURPOSE OF REVIEW: Superior vena cava (SVC) is one of the most important nonpulmonary vei

260 ate the causes and symptoms of superior vena cava (SVC) obstruction or occlusion and report on the lo

261 veins of the thorax including superior vena cava (SVC), brachiocephalic (BCV), subclavian (SCV) and

262 ey resided anywhere within the superior vena cava (SVC).

263 om vascular obstruction of the superior vena cava (SVC).

264 Specifically, superior vena cava syndrome may warrant radiation, chemotherapy, vascu

265 Superior vena cava syndrome was more common in the non-cardiac surgica

266 epartment with symptoms of the superior vena cava syndrome.

267 o aorto-iliac/visceral arteries and the vena cava (temporal resolution, five images per second; and s

268 slope was significantly higher for the vena cava than atrial IDIF (mL/g/min, ctl: 0.11+/-0.02 vs. 0.

269 incipal discharge diagnosis of inferior vena cava thrombosis (International Classification of Disease

270 Vena cava thrombosis can represent a surgical challenge in th

271 the treatment of patients with inferior vena cava thrombosis in the United States.

272 ysis (CDT) in the treatment of inferior vena cava thrombosis is unknown.

273 ng 2674 patients admitted with inferior vena cava thrombosis, 718 (26.9%) underwent CDT.

274 included filter-related acute inferior vena cava thrombosis, chronic inferior vena cava occlusion, a

275 diopulmonary bypass because of extended vena cava thrombosis; in 2 patients, a simultaneous sternotom

276 he right or left lung into the inferior vena cava, through drainage into the hepatic vein, right atri

277 The vena cava time-activity curve is therefore a minimally invasi

278 n of a balloon catheter in the inferior vena cava to identify the lower limit of cerebral autoregulat

279 positioned in the retrohepatic inferior vena cava to shunt hepatic venous effluent through an activat

280 Puncture through the inferior vena cava to the pulmonary venous atrium may be an effective

281 urgical crossing from a donor (superior vena cava) to a recipient (PA) vessel and endovascular stent-

282 Mouse inferior vena cava-to-carotid interposition isografts were completed u

283 nd collapsibility index of the inferior vena cava under a deep standardized inspiration using transth

284 cipient hepatectomy rendered the native vena cava unsalvageable.

285 ion, mitral regurgitation, and inferior vena cava variability) and correlated abnormalities in select

286 ecruitment of platelets to the inferior vena cava wall after DVT induction were reduced in MC-deficie

287 ull mice in which a segment of inferior vena cava was grafted into the right carotid artery at 16 wee

288 lus empirical isolation of the superior vena cava was performed in all.

289 arctation, and persistent left superior vena cava was significantly associated with women with TS.

290 In addition, the donor vena cava was too short to bridge the caval defect for interp

291 the catheter, access vein, and cranial vena cava were dissected, removed en bloc, and fixed in forma

292 r pulmonary vein antra and the superior vena cava were isolated using an ICE-guided technique.

293 ft atrium, coronary sinus, and superior vena cava were targeted for ablation.

294 pulmonary veins, including the superior vena cava, were successfully isolated.

295 nment defects, and interrupted inferior vena cava with azygos continuation.

296 gallbladder and an interrupted inferior vena cava with azygous continuation.

297 nd the percent collapse of the inferior vena cava with inspiration (collapsibility index) by ultrasou

298 duced enhanced uptake of virions in the vena cava with selective transgene expression.

299 onic indwelling CVC in the low superior vena cava with thrombus in situ was established after feasibi

300 a flattened right lobar portal vein and vena cava without any visible active bleeding.